Fonte: Scientific Reports. Unidade: FMRP
Assuntos: SÍNDROME DO INTESTINO IRRITÁVEL, ANTIPARASITÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOTSCHUIJVER, Sara et al. Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms. Scientific Reports, v. 9, 2019Tradução . . Disponível em: https://doi.org/10.1038/s41598-019-49096-y. Acesso em: 25 set. 2024.APA
Botschuijver, S., van Diest, S. A., van Thiel, I. A. M., Saia, R. S., Strik, A. S., Yu, Z., et al. (2019). Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms. Scientific Reports, 9. doi:10.1038/s41598-019-49096-yNLM
Botschuijver S, van Diest SA, van Thiel IAM, Saia RS, Strik AS, Yu Z, Maria-Ferreira D, Welting O, Keszthelyi D, Jennings G, Heinsbroek SEM, Elferink RP, Schuren FHJ, Jonge WJ de, Wijngaard RM van den. Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms [Internet]. Scientific Reports. 2019 ; 9[citado 2024 set. 25 ] Available from: https://doi.org/10.1038/s41598-019-49096-yVancouver
Botschuijver S, van Diest SA, van Thiel IAM, Saia RS, Strik AS, Yu Z, Maria-Ferreira D, Welting O, Keszthelyi D, Jennings G, Heinsbroek SEM, Elferink RP, Schuren FHJ, Jonge WJ de, Wijngaard RM van den. Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms [Internet]. Scientific Reports. 2019 ; 9[citado 2024 set. 25 ] Available from: https://doi.org/10.1038/s41598-019-49096-y